Literature DB >> 25794985

Effect of phytochemical intervention on dibenzo[a,l]pyrene-induced DNA adduct formation.

Gilandra K Russell1, Ramesh C Gupta2, Manicka V Vadhanam3.   

Abstract

Dibenzo[a,l]pyrene (DBP) has been found to be the most potent carcinogen of the polycyclic aromatic hydrocarbons (PAHs). Primary sources for DBP in the environment are combustion of wood and coal burning, gasoline and diesel exhaust, and tires. Given the likelihood of environmental exposure to DBP and strong experimental evidence of its potency, it is likely to contribute to lung cancer development. Intervention with compounds of natural origin ("phytochemicals") is considered an effective means to prevent cancer development and favorably modulate the underlying mechanisms, including DNA adduct formation. In this study, several agents have been identified that inhibit environmental carcinogen-induced DNA adduct formation using a cell-free microsomal system. Of the ten agents tested, resveratrol (648 ± 26 adducts/10(9) nucleotides), oltipraz (1007 ± 348 adducts/10(9) nucleotides), delphinidin (1252 ± 142 adducts/10(9) nucleotides), tanshinone I (1981 ± 213 adducts/10(9) nucleotides), tanshinone IIA (2606 ± 478 adducts/10(9) nucleotides) and diindoylmethane (3643 ± 469 adducts/10(9) nucleotides) were the most effective compared to vehicle treatment (14,062 ± 1097 adducts/10(9) nucleotides). DBP is metabolized by phase I metabolizing enzymes CYP1A1, CYP1A2, and CYP1B1. DBP-induced DNA adducts can be inhibited by several mechanisms. We found that all the test agents inhibited DNA adducts by inhibiting one or more of these enzymes. Oltipraz inhibited DNA adducts entirely by inhibiting the CYP450s, while resveratrol and delphinidin inhibited DNA adducts by also interacting directly with the carcinogenic metabolite, anti-dibenzo(a,l)pyrene-11,12-dihydrodiol-13,14-epoxide.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (32)P-postlabeling; Cytochrome P450; DNA adducts; Dibenzo[a,l]pyrene; Polycyclic aromatic hydrocarbons

Mesh:

Substances:

Year:  2015        PMID: 25794985      PMCID: PMC4402140          DOI: 10.1016/j.mrfmmm.2015.02.003

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  29 in total

Review 1.  Cancer chemoprevention by dietary constituents: a tale of failure and promise.

Authors:  A J Gescher; R A Sharma; W P Steward
Journal:  Lancet Oncol       Date:  2001-06       Impact factor: 41.316

2.  Ultimate electrophilic carcinogens on cellular nucleophilic reactants. A contribution to the discussion on threshold doses of environmental chemicals.

Authors:  H G Neumann
Journal:  Arch Toxicol       Date:  1974-03-29       Impact factor: 5.153

3.  Direct fluorometric methods for measuring mixed function oxidase activity.

Authors:  R A Prough; M D Burke; R T Mayer
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7.

Authors:  W A Smith; J W Freeman; R C Gupta
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

5.  The effect of ellagic acid on the uptake, persistence, metabolism and DNA-binding of benzo[a]pyrene in cultured explants of strain A/J mouse lung.

Authors:  R W Teel; R Dixit; G D Stoner
Journal:  Carcinogenesis       Date:  1985-03       Impact factor: 4.944

6.  Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes.

Authors:  Bertrand Piver; Maude Fer; Xavier Vitrac; Jean-Michel Merillon; Yvonne Dreano; François Berthou; Danièle Lucas
Journal:  Biochem Pharmacol       Date:  2004-08-15       Impact factor: 5.858

7.  Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves.

Authors:  Bolleddula Jayaprakasam; Yanjun Zhang; Navindra P Seeram; Muraleedharan G Nair
Journal:  Life Sci       Date:  2003-11-21       Impact factor: 5.037

Review 8.  [Anticancer effect of tanshinone and its mechanisms].

Authors:  Shu-Lan Yuan; Xiu-Jie Wang; Yu-Quan Wei
Journal:  Ai Zheng       Date:  2003-12

9.  The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

Authors:  G A Potter; L H Patterson; E Wanogho; P J Perry; P C Butler; T Ijaz; K C Ruparelia; J H Lamb; P B Farmer; L A Stanley; M D Burke
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

10.  Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene.

Authors:  G Berge; S Øvrebø; E Eilertsen; A Haugen; S Mollerup
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more
  3 in total

1.  Resveratrol-3-O-glucuronide and resveratrol-4'-O-glucuronide reduce DNA strand breakage but not apoptosis in Jurkat T cells treated with camptothecin.

Authors:  Susan J Zunino; David H Storms
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

2.  Chemoprevention of Colorectal Cancer by Anthocyanidins and Mitigation of Metabolic Shifts Induced by Dysbiosis of the Gut Microbiome.

Authors:  Ashley M Mudd; Tao Gu; Radha Munagala; Jeyaprakash Jeyabalan; Nejat K Egilmez; Ramesh C Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2019-12-03

Review 3.  Chemopreventive effect of natural dietary compounds on xenobiotic-induced toxicity.

Authors:  Jia-Ching Wu; Ching-Shu Lai; Mei-Ling Tsai; Chi-Tang Ho; Ying-Jan Wang; Min-Hsiung Pan
Journal:  J Food Drug Anal       Date:  2016-12-07       Impact factor: 6.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.